Importance of clinically actionable results in genetic panel testing for cancer
Authors cite urgent need for larger studies in diverse populations to provide accurate cancer risk estimates
2015-05-27
(Press-News.org) Philadelphia - While advances in technology have made multigene testing, or "panel testing," for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal of Medicine say larger studies are needed in order to provide reliable risk estimates for counseling these patients. The international consortium of authors, including researchers at the Basser Center for BRCA at the University of Pennsylvania's Abramson Cancer Center, acknowledges that panel testing can make a useful contribution to predicting a woman's risk of breast cancer, but says clinicians need to be aware of the limitations. The note of caution comes following news of low-cost genetic testing solutions for breast and ovarian cancer mutations.
Panel testing can cover more than 100 genes, 21 of which are cited as increasing a patient's risk of breast cancer. However, recent studies suggest that because there is a lack of information about many genetic variants, multiplex testing may cause undue anxiety and stress over findings which may turn out to be benign. In addition, some researchers are concerned that positive results for genetic mutations may lead patients to take significant and potentially unnecessary risk-reducing or screening interventions based on very limited information.
The review considers evidence for specific genes where there is some reported association with an increased risk of breast cancer. For many - such as RAD51C, RAD51D, and BRIP1 which show clear evidence of association with ovarian cancer - the association with breast cancer is limited. In most instances, the evidence does not reach the level of evidence threshold proposed by the authors.
"While there is clear evidence between some genetic variants and an increased risk of breast cancer - such as BRCA1 and BRCA2, for which there is an overwhelming body of evidence - risk estimates for many other mutations are far too imprecise at this stage and require further investigation," said co-author Susan M. Domchek, MD, director of the Basser Center for BRCA, and the Basser Professor of Oncology in Penn's Abramson Cancer Center and Perelman School of Medicine. "Until we have a better understanding of associated risks of the range of genes found on these panels, individuals who are undergoing panel testing need to be informed of the potential for uncertainty regarding results."
INFORMATION:
Katherine L. Nathanson, MD, associate director for Population Sciences in the Abramson Cancer Center, and director of Genetics in the Basser Center for BRCA, is also a co-author on the review.
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-27
Boulder, Colo., USA - Salt rock behaves as a fluid and can play a pivotal role in the large-scale, long-term collapse of the world's continental margins. However, the precise way in which this occurs is laced in controversy; nowhere is this controversy more apparent than along the Brazilian continental margin, where the origin of a feature called "the Albian Gap" has generated much heated debate over several decades.
In this new, open-access GSA Bulletin article, Christopher A-L. Jackson and colleagues enter this debate, critiquing the geological and geophysical evidence ...
2015-05-27
Biologists at UC San Diego have discovered that a tiny single-celled parasite may have a greater-than expected impact on honey bee colonies, which have been undergoing mysterious declines worldwide for the past decade.
In this week's issue of the journal PLOS ONE, (see http://dx.plos.org/10.1371/journal.pone.0126330), the scientists report that a microsporidian called Nosema ceranae, which has been known to infect adult Asiatic and European honey bees, can also infect honeybee larvae. They also discovered that honey bee larvae infected with the microsporidian have reduced ...
2015-05-27
Scientists at the University of California, San Diego and the Massachusetts Institute of Technology (MIT) have described a new method for detecting liver cancer metastases in mice. The approach uses over-the-counter probiotics genetically programmed to produce signals easily detectable in urine when liver cancer metastases are present. The results of the new study, published in the May 27 issue of Science Translational Medicine, indicate that genetically-programmed probiotics may be useful for detecting liver cancer metastases early-on in the progression of the disease. ...
2015-05-27
A rigorous analysis of more than 3,000 antimalarials purchased in Enugu, Nigeria found 9.3% to be of poor quality, according to new research published in PLOS ONE.
Researchers found 1.2% of the samples to be falsified and 1.3% to be degraded, but raised bigger concerns about 6.8% being of substandard manufacture, leaving patients at risk of not receiving the correct treatment dose and potentially contributing to the development of resistance to the main drug used to treat malaria.
The drug quality team of the Artemisinin-based Combination Therapy (ACT) Consortium ...
2015-05-27
PITTSBURGH, May 27, 2015 - Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's top academic medical centers in today's online issue of Science Translational Medicine.
Led by Arthur S. Levine, M.D., the University of Pittsburgh senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of Medicine, medical school deans from 18 institutions reviewed the financial challenges ...
2015-05-27
CAMBRIDGE, MA -- Engineers at MIT and the University of California at San Diego (UCSD) have devised a new way to detect cancer that has spread to the liver, by enlisting help from probiotics -- beneficial bacteria similar to those found in yogurt.
Many types of cancer, including colon and pancreatic, tend to metastasize to the liver. The earlier doctors can find these tumors, the more likely that they can successfully treat them.
"There are interventions, like local surgery or local ablation, that physicians can perform if the spread of disease in the liver is confined, ...
2015-05-27
Given the aging of the population and the low birthrate both in Japan and elsewhere, healthcare professionals are in short supply and unevenly distributed, giving rise to a need for alternatives to humans for performing simple tasks. Although increasing numbers of medical institutions have introduced electronic medical records, a variety of issues remain unresolved, such as the inconvenience of data recording and the high costs associated with data input.
The use of robots to support medical care data management and the delivery of resources at the medical front--thus ...
2015-05-27
A breakthrough in machine learning has also brought about a "game changer" for the science of metabolomics - and will hasten the development of diagnostic and predictive tests for Alzheimer's, cancer, diabetes and numerous other conditions, leading to improved prevention and treatment.
University of Alberta computing science PhD graduate Siamak Ravanbakhsh published his research in the scientific journal PLOS ONE on an automated process that increases the speed and accuracy of producing a person's metabolic profile from a sample of biofluid such as blood serum or cerebrospinal ...
2015-05-27
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count--a key measure of immune system health--is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
The ...
2015-05-27
(Boston)--Reductions in federal support and clinical revenue not only jeopardize biomedical research at academic medical centers, but may ultimately impact clinical medicine according to an opinion piece in the journal Science Translational Medicine.
Biomedical research is crucial to the US national agenda and academic medical centers--the provenance for much of this research - are at particular risk, according to the authors. Persistent constraints on federal funding threaten to undermine this, and decreasing clinical revenue due to increasingly constrained reimbursement ...
LAST 30 PRESS RELEASES:
[Press-News.org] Importance of clinically actionable results in genetic panel testing for cancer
Authors cite urgent need for larger studies in diverse populations to provide accurate cancer risk estimates
